Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

Area of Science:

• Molecular Biology
• Cancer Metabolism
• Hematology

Background:

• Acute myeloid leukemia (AML) cells dynamically adapt their metabolism in response to the bone marrow (BM) microenvironment.
• Adipocytes, abundant in the BM stroma, increase with age and are remodeled by AML, potentially supporting leukemia survival.
• Fatty acid oxidation (FAO) is implicated in leukemia stem cell quiescence and drug resistance.

Purpose of the Study:

• To review recent advancements in understanding fatty acid metabolism in AML cells within the adipocyte-rich BM niche.
• To discuss the therapeutic potential of targeting FAO in chemoresistant leukemia.

Main Methods:

• Review of current experimental evidence and literature.
• Analysis of metabolic pathways, specifically fatty acid oxidation (FAO).
• Discussion of therapeutic strategies involving FAO inhibitors.

Main Results:

• AML induces lipolysis of bone marrow adipocytes, providing fatty acids for AML cell metabolism.
• Fatty acid oxidation (FAO) generates acetyl-CoA and can uncouple mitochondrial oxidative phosphorylation.
• FAO is linked to quiescence and chemoresistance in leukemia stem cells.

Conclusions:

• Fatty acid metabolism plays a critical role in AML cell survival and drug resistance within the bone marrow microenvironment.
• Combinatorial therapies incorporating FAO inhibitors present a promising approach to target metabolic vulnerabilities in chemoresistant AML.